A Systematic Review and Network Meta-Analysis about the Efficacy and Safety of Tripterygium wilfordii Hook F in Rheumatoid Arthritis

Table 2

Ranking probability of different conventional synthetic DMARDs.

Treatment	ACR20		ACR50		ACR70		Adverse events
	SUCRA	Rank	SUCRA	Rank	SUCRA	Rank	SUCRA	Rank
T	0.749	2	0.726	3	0.606	3	0.107	11
M + T	0.867	1	0.87	2	0.646	2	0.146	10
M	0.371	9	0.457	6	0.261	9	0.441	6
M + S	0.603	6	0.603	5	0.457	7	0.616	4
L	0.263	10	0.397	7	0.508	6	0.524	5
L + T	0.397	8	0.607	4	0.852	4	0.723	3
L + C	0.661	4	0.95	1	0.915	1	0.352	9
C	0.664	3	0.374	8	0.542	5	0.415	7
S	0.245	11	0.246	10	0.156	10	0.403	8
F	0.639	5	0.254	9	0.428	8	0.836	2
Mi	0.505	7	—	—	—	—	—	—
P	0.035	12	0.016	11	0.131	11	0.936	1

TwHF, Tripterygium wilfordii Hook F; MTX, methotrexate, LEF; leflunomide; SSZ, sulfasalazine; CsA, cyclosporine; FK506, tacrolimus; and MINO, minocycline; M, MTX; T, TwHF; M + T, TwHF combined with MTX; L, LEF; L + T, TwHF combined with LEF; S, SSZ; M + S, SSZ combined with MTX; C, CsA; L + C; CsA combined with LEF; F, FK506; Mi, MINO; P, placebo.